Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus
The DOI matches its Crossref record, with a small difference in title or year; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Objectives This study was undertaken to determine the frequencies of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes.Study design This was a prospective observation of pregnancy outcomes among 462 women with pregestational diabetes mellitus (White classes B-F) and singleton pregnancies who were enrolled in a multicenter trial to compare low-dose aspirin with placebo for preeclampsia prevention. The main outcome measures were preeclampsia and neonatal outcomes.Results Among 462 women with pregestational diabetes, 92 (20%) had preeclampsia. Preeclampsia frequency rose significantly with increasing severity of diabetes according to White classification (class B, 11%; class C, 22%; class D, 21%; class R plus class F, 36%; P <.0001). Preeclampsia was also more common among women who had proteinuria at baseline (28% vs 18%; odds ratio, 1.75; 95% confidence interval, 1.02-3.01). Frequency of preterm delivery at <35 weeks' gestation rose greatly with increasing severity of diabetes (P =.0002). Women with proteinuria at baseline were significantly more likely to be delivered at <35 weeks' gestation (29% vs 13%; odds ratio, 2.6; 95% confidence interval, 1.5-4.6) and to have small-for-gestational-age infants (14% vs 3%; odds ratio, 5. 4; 95% confidence interval, 2.7-17.7), and they were less likely to have large-for-gestational-age infants (14% vs 40%; odds ratio, 0.2; 95% confidence interval, 0.1-0.5).Conclusion Among women with pregestational diabetes mellitus, the frequency of preeclampsia rose with increasing severity of diabetes. Proteinuria early in pregnancy was associated with marked increases in adverse neonatal outcomes independent of preeclampsia development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Renal dysfunction in a pregnant woman with type 1 diabetes is associated with an increased risk of adverse maternal and fetal outcomes, including an increased risk of preeclampsia (46–48).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [46]
Citations
Cites
A standard of fetal growth for the united states of America
Brenner, W. E., Edelman, D. A., & Hendricks, C. H. (1976) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(76)90748-1 · Cited by 836
Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk
Caritis, S., Sibai, B., Hauth, J., Lindheimer, M. D., Klebanoff, M., Thom, E., VanDorsten, P., Landon, M., Paul, R., Miodovnik, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381101 · Cited by 664
Self-citationSibai, B. M., Lindheimer, M., Hauth, J., Caritis, S., VanDorsten, P., Klebanoff, M., MacPherson, C., Landon, M., Miodovnik, M., Paul, R., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391004 · Cited by 500
Self-citationDoes pregnancy increase the risk for development and progression of diabetic nephropathy?
Miodovnik, M., Rosenn, B., Khoury, J. C., Grigsby, J. L., & Siddiqi, T. A. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70660-9 · Cited by 148
Self-citationHanson, U., & Persson, B. (1993) · American Journal of Perinatology · doi:10.1055/s-2007-994754 · Cited by 140
Predictors of pre-eclampsia in women at high risk
Caritis, S. N., Sibai, B. M., Hauth, J. C., Lindheimer, M. D., VanDorsten, P., Klebanoff, M. A., Thom, E. A., Landon, M. B., Paul, R., Miodovnik, M., et al. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70194-2 · Cited by 127
Self-citationPerinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy
Gordon, M. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00420-3 · Cited by 125
Type I diabetes mellitus and pregnancy
Garner, P. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91213-4 · Cited by 125
Diabetic nephropathy: Pregnancy performance and fetomaternal outcome
Reece, E. A., Coustan, D. R., Hayslett, J. P., Holford, T. R., Coulehan, J., O’Connor, T., & Hobbins, J. C. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90494-2 · Cited by 97
Hanson, U., & Persson, B. (1998) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1998.770608.x · Cited by 79
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Savvidou, M. D., Hingorani, A. D., Tsikas, D., Frölich, J. C., Vallance, P., & Nicolaides, K. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13177-7 · Cited by 514
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 470
Metadata
- Authors
- Sibai, B. M., Caritis, S., Hauth, J., Lindheimer, M., VanDorsten, J. P., MacPherson, C., Klebanoff, M., Landon, M., Miodovnik, M., Paul, R., Meis, P., Dombrowski, M., Thurnau, G., Roberts, J., & McNellis, D.
- Affiliations
- University of Tennessee Health Science Center (US)
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2000-02
- Volume
- 182
- Issue
- 2
- Pages
- 364-369
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2091154799
- Cited by
- 222
- References
- 14
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 11 · 2023: 12 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 12 · 2017: 9 · 2016: 11 · 2015: 10 · 2014: 5 · 2013: 12 · 2012: 7
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- American Journal of Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD19897, HD-21414, [HD21410, U01HD019897)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- pregestational diabetes, preeclampsia, adverse neonatal outcomes, diabetes severity, proteinuria, preterm birth, small for gestational age, large for gestational age, low-dose aspirin, preeclampsia prevention
- MeSH terms
- Aspirin, Birth Weight, Blood Pressure, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Hypertension, Infant, Newborn, Infant, Premature, Infant, Small for Gestational Age, Platelet Aggregation Inhibitors, Pre-Eclampsia, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Prenatal Care, Proteinuria, Thrombocytopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. https://app.cochat.ai/papers/10.1016/s0002-9378(00)70225-0
- The paper
- Sibai, B. M., Caritis, S., Hauth, J., Lindheimer, M., VanDorsten, J. P., MacPherson, C., Klebanoff, M., Landon, M., Miodovnik, M., Paul, R., Meis, P., Dombrowski, M., Thurnau, G., Roberts, J., & McNellis, D. (2000). Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/s0002-9378(00)70225-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.